ACR highlights. Many Scleroderma trials were close to positive. Tocilizumab, Abatacept & Riociguat. In PsA safety and effectiveness of IL17 and also apremilast persist. Jaki safety and benefit in RA and no new signals of VTE. New SLE criteria #ACR18 @RheumNow